Dexamethasone suppression test (long)
Last updated: Thursday, 15, April, 2004
MBS Online Search Page: Click here for details
| Item | Process |
|---|---|
| Specimen | The test is done as an inpatient procedure. |
| Method | See Cortisol - urine, Cortisol - plasma or serum and Adrenocorticotrophic hormone. |
| Protocol | Two days basal (no dexamethasone); then dexamethasone at low dose (0.5 mg qid) for two days; and high dose (2 mg qid) for a further two days.
|
| Reference Interval | Suppression is defined as a reduction of cortisol to <50% of the basal value. |
| Application | Definitive diagnosis in a patient with an abnormal (overnight) dexamethasone suppression test. |
| Interpretation | Suppression of cortisol levels on dexamethasone 2 mg/day excludes Cushing’s syndrome. Failure to suppress cortisol after 2 mg/day, with suppression on 8 mg/day, indicates pituitary Cushing’s syndrome (Cushing’s disease). Failure to suppress cortisol on 8 mg/day indicates adrenal neoplasm or ectopic ACTH syndrome. In Cushing’s disease, ACTH is suppressed by high dose dexamethasone; in the ectopic ACTH syndrome, ACTH is not suppressed; in adrenal neoplasia, ACTH levels are low in the baseline specimen. |
| Reference | Orth DN et al. In: Wilson JD and Foster DW eds. Williams Textbook of Endocrinology. 8th ed. WB Saunders 1992. |
